AS
Aarti Sharma
About Aarti Sharma
Data last updated:
Aarti Sharma was a Director at Aleris Reality Private Limited (2017–2019), Director at Alventa Pharma Limited (2016–2018) and Director at Strebuf Pharma Private Limited (from 2018), and held 3 more directorships. The companies operate in Financial Services and Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aleris Reality Private Limited U70109WB2011PTC159264 | Director | 27 Jan 2017 | 2011 | ₹2.5 Lakh (FY 2022) | Active |
 Alventa Pharma Limited U24299WB2016PLC225674 | Director | 28 Oct 2016 | 2016 | ₹143 Cr (FY 2025) | Active |
| Strebuf Pharma Private Limited U24100WB2010PTC141915 | Director | 16 Aug 2018 | 2010 | Strike Off | |
| Gayatri Drugs Private Limited U24232WB2010PTC144951 | Director | 08 Nov 2016 | 2010 | Strike Off | |
| Purna Pharma Private Limited U74900WB2015PTC206920 | Director | 27 Jan 2017 | 2015 | Strike Off | |
| Gayatri Generics Private Limited U24232WB2010PTC144952 | Director | 16 Aug 2018 | 2010 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aarti Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aarti Sharma
Aarti Sharma was first appointed on 28 Oct 2016 as Director at Alventa Pharma Limited. The most recent appointment on record is 16 Aug 2018 at Gayatri Generics Private Limited.
Aarti Sharma held 6 earlier board appointments: Aleris Reality Private Limited (Director, 27 Jan 2017 to 14 Dec 2019); Alventa Pharma Limited (Director, 28 Oct 2016 to 04 Jun 2018); Strebuf Pharma Private Limited (Director, from 16 Aug 2018); Gayatri Drugs Private Limited (Director, from 08 Nov 2016); Purna Pharma Private Limited (Director, from 27 Jan 2017); and 1 more.